NCT05965128 Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases
| NCT ID | NCT05965128 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Huashan Hospital |
| Condition | Respiratory Infectious Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,255 participants |
| Start Date | 2022-12-01 |
| Primary Completion | 2023-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,255 participants in total. It began in 2022-12-01 with a primary completion date of 2023-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Relying on fever clinics, this project evaluates the clinical diagnostic efficiency of the three-level pathogen diagnostic system, monitors changes in respiratory pathogens, and realizes real-time monitoring and early warning of acute respiratory infectious diseases in Shanghai.
Eligibility Criteria
Inclusion Criteria: 1. Acute onset within one week; 2. 18-70 years old; 3. Present with pneumonia (present with pulmonary signs or radiological changes) or influenza-like illness (including the following symptoms: sudden onset of fever (\>38 ℃),plus cough and/or other respiratory symptoms such as shortness of breath plus one or more systemic symptoms (fatigue, headache ect.)) Exclusion Criteria: 1. Unable to collect nasal/nasopharyngeal swab/wash/aspirate due to structural disorder or mental problem. 2. Patients with psycological problem or unconsciousness who cannot tell the disease history and cooperate with medical examinations;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05965128 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 100 Years, studying Respiratory Infectious Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05965128 currently recruiting?
Yes, NCT05965128 is actively recruiting participants. Contact the research team at zhangwenhong@fudan.edu.cn for enrollment information.
Where is the NCT05965128 trial being conducted?
This trial is being conducted at Lanzhou, China, Harbin, China, Hohhot, China, Suzhou, China and 8 additional locations.
Who is sponsoring the NCT05965128 clinical trial?
NCT05965128 is sponsored by Huashan Hospital. The trial plans to enroll 1,255 participants.